Biblio
Application of CMV-IVIg as prophylaxis against cytomegalovirus reactivation in allogeneic hematopoietic stem cell transplantation patients. Clin Transplant. 2024;38(4):e15300.
. Generation of a PPM1A-deficient human induced pluripotent stem cell line using CRISPR-Cas9 technology. Stem Cell Res. 2024;77:103420.
. Generation of an NSD2-deficient human embryonic stem cell line using CRISPR/Cas9 technology. Stem Cell Res. 2023;73:103255.
. Differential expression and role of miR-200 family in multiple tumors. Anal Biochem. 2021:114243.
.